GE HealthCare Technologies Inc. (GEHC) Earnings History
Annual and quarterly earnings data from 2020 to 2025
Loading earnings history...
GEHC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GEHC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 40.0% | 13.4% | 10.1% |
| 2024 | 41.7% | 13.3% | 10.1% |
| 2023 | 40.5% | 12.5% | 8.0% |
| 2022 | 39.1% | 13.8% | 10.4% |
| 2021 | 40.8% | 15.9% | 12.8% |
Download Data
Export GEHC earnings history in CSV or JSON format
Free sign-in required to download data
GE HealthCare Technologies Inc. (GEHC) Earnings Overview
As of May 8, 2026, GE HealthCare Technologies Inc. (GEHC) reported trailing twelve-month net income of $1.50B, reflecting +4.8% year-over-year growth. The company earned $3.29 per diluted share over the past four quarters, with a net profit margin of 10.1%.
Looking at the long-term picture, GEHC's 5-year EPS compound annual growth rate (CAGR) stands at +0.6%, reflecting modest earnings expansion. The company achieved its highest annual net income of $13.85B in fiscal 2020.
GE HealthCare Technologies Inc. maintains positive profitability with a gross margin of 40.0%, operating margin of 13.4%, and net margin of 10.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including SYK ($3.25B net income, 12.9% margin), BSX ($2.89B net income, 14.4% margin), EW ($1.07B net income, 17.7% margin), GEHC has room to improve margins relative to the peer group. Compare GEHC vs SYK →
GEHC Earnings vs Peers
Earnings metrics vs comparable public companies
GEHC Historical Earnings Data (2020–2025)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.08B | +4.6% | $2.76B | $4.55 | 10.1% | 13.4% |
| 2024 | $1.99B | +27.1% | $2.63B | $4.34 | 10.1% | 13.3% |
| 2023 | $1.57B | -18.2% | $2.44B | $3.02 | 8.0% | 12.5% |
| 2022 | $1.92B | -14.7% | $2.52B | $4.22 | 10.4% | 13.8% |
| 2021 | $2.25B | -83.8% | $2.79B | $4.90 | 12.8% | 15.9% |
| 2020 | $13.85B | - | $2.72B | $4.41 | 80.7% | 15.8% |
Full GEHC Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See GEHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GEHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GEHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGEHC — Frequently Asked Questions
Quick answers to the most common questions about buying GEHC stock.
Is GEHC growing earnings?
GEHC EPS of $3.29 reflects slowing growth at +4.8%, below the 5-year CAGR of +0.6%. TTM net income is $1.5B. Expansion rate has moderated.
What are GEHC's profit margins?
GE HealthCare Technologies Inc. net margin is +10.1%, with operating margin at +13.4%. Margins sit within typical range for the sector.
How consistent are GEHC's earnings?
GEHC earnings data spans 2020-2025. The current earnings trend is +4.8% YoY. Historical data enables comparison across business cycles.